Companies: 10,795·Total market cap: $144.5T
bluebird bio, Inc.

bluebird bio, Inc.

BLUENASDAQHealthcare
$4.97
+$0.00(+0.00%)
Market Cap$48668526
P/E Ratio
52W High$28.6
52W Low$3.2
Overview

bluebird bio, Inc. (BLUE) Revenue

Annual & quarterly revenue history · segment & region breakdown

BLUE · revenue · updated Jun 10, 2026

Core revenue metrics

bluebird bio, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
248 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · bluebird bio, Inc. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
BLUE revenue by year · BLUE revenue history · BLUE annual revenue data

Compare revenue vs peers

Biotechnology

Compare BLUE revenue against listed peers. Click any row to open that company's revenue tab.

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income bluebird bio, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

bluebird bio, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from bluebird bio, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

BLUE revenue · 4 questions

BLUE's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

BLUE revenueBLUE annual revenuewhat is BLUE revenueBLUE TTM revenue

Source: FMP · bluebird bio, Inc. SEC filings · GAAP · bluebird bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026